Platform Technology Partners
BMY icon

Platform Technology Partners’s Bristol-Myers Squibb BMY Stock Holding History

Platform Technology Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.27M Buy
20,388
+3
+0% +$190 0.2% 99
2026
Q2 		$1.17M Sell
20,385
-1,132
-5% -$65K 0.19% 109
2026
Q1 		$1.3M Buy
21,517
+1,293
+6% +$75.4K 0.25% 92
2025
Q4 		$1.09M Sell
20,224
-1,767
-8% -$85K 0.23% 98
2025
Q3 		$992K Sell
21,991
-1,274
-5% -$59.5K 0.24% 101
2025
Q2 		$1.08M Sell
23,265
-273
-1% -$13.4K 0.28% 90
2025
Q1 		$1.44M Sell
23,538
-652
-3% -$38K 0.42% 65
2024
Q4 		$1.37M Buy
24,190
+67
+0.3% +$3.74K 0.41% 62
2024
Q3 		$1.25M Sell
24,123
-1,113
-4% -$52.2K 0.39% 70
2024
Q2 		$1.05M Buy
+25,236
New +$1.13M 0.36% 72
2023
Q4 		$1.34M Buy
26,906
+2,908
+12% +$153K 0.52% 58
2023
Q3 		$1.39M Sell
23,998
-318
-1% -$19.5K 0.65% 43
2023
Q2 		$1.53M Sell
24,316
-693
-3% -$46.5K 0.72% 36
2023
Q1 		$1.73M Sell
25,009
-420
-2% -$29.6K 0.86% 32
2022
Q4 		$1.83M Buy
25,429
+304
+1% +$22.9K 0.95% 26
2022
Q3 		$1.79M Sell
25,125
-372
-1% -$27K 1.02% 22
2022
Q2 		$1.96M Sell
25,497
-258
-1% -$19.6K 1.07% 22
2022
Q1 		$1.88M Sell
25,755
-398
-2% -$26.7K 0.9% 22
2021
Q4 		$1.63M Sell
26,153
-569
-2% -$33.4K 0.72% 30
2021
Q3 		$1.58M Sell
26,722
-1,959
-7% -$129K 0.72% 31
2021
Q2 		$1.92M Buy
+28,681
New +$1.87M 0.79% 21
2020
Q4 		$2.03M Buy
32,741
+127
+0.4% +$7.81K 0.99% 16
2020
Q3 		$1.97M Buy
32,614
+1,632
+5% +$98.2K 1.2% 14
2020
Q2 		$1.82M Buy
30,982
+1,308
+4% +$78.2K 1.28% 14
2020
Q1 		$1.65M Buy
29,674
+4,323
+17% +$264K 1.51% 13
2019
Q4 		$1.63M Buy
+25,351
New +$1.45M 1.23% 15

Other funds holding BMY

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Platform Technology Partners's BMY Position: Q3 2026 in Review

Platform Technology Partners increased its Bristol-Myers Squibb (BMY) stake by 0.01% in Q3 2026, buying an estimated $190 and bringing the position to 20,388 shares worth $1.27M. The position accounts for 0.2% of the portfolio, ranked #99.

Platform Technology Partners first reported a position in BMY in Q4 2019 and has held it in 26 quarters since. The position peaked at $2.03M in Q4 2020. 1,187 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Platform Technology Partners held 20,388 shares of Bristol-Myers Squibb worth $1.27M as of Q3 2026.
  • Platform Technology Partners bought 3 Bristol-Myers Squibb shares in Q3 2026, an estimated $190.
  • Bristol-Myers Squibb made up 0.2% of Platform Technology Partners's portfolio in Q3 2026, its #99 holding.
  • Platform Technology Partners first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 26 quarters since.
  • Platform Technology Partners's Bristol-Myers Squibb position peaked at $2.03M in Q4 2020.
  • 1,187 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Platform Technology Partners's 13F filing for Q3 2026, filed 2 Nov 2026.